Back

GPATCH11 variants cause mis-splicing and early-onset retinal dystrophy with neurological impairment

Zanetti, A.; Fares Taie, L.; Amiel, J.; David, P.; Moriceau, S.; Goudin, N.; Roger, J.; Guerrera, I. C.; Jung, V.; Gitiaux, C.; Audo, I.; Robert, M.; Boddaert, N.; Sigaudy, S.; Philip-Sarles, N.; Briault, S.; Rivolta, C.; Kaminska, K.; Amana, D.; Bruel, A.-L.; Thauvin, C.; Kaplan, J.; Rozet, J.-M.; Perrault, I.

2023-08-21 genetic and genomic medicine
10.1101/2023.08.19.23293832 medRxiv
Show abstract

Spliceosome and ciliary dysfunctions can lead to remarkably similar clinical syndromes. Studying ten individuals with retinal dystrophy, neurological involvement, and skeletal abnormalities, suggestive of both spliceosomopathies and ciliopathies, we involved GPATCH11, a lesser-known GPATCH-domain-containing regulators of RNA metabolism. To elucidate GPATCH11 function, we employed fibroblasts from unaffected individuals and patients carrying a recurring mutation specifically removing the main part of the GPATCH-domain while preserving other domains. Additionally, we generated a mouse model replicating the patients genetic defect, exhibiting behavioural abnormalities and retinal dystrophy. Our findings revealed GPATCH11 unique subcellular localization, marked as foci staining pattern and a diffuse presence in the nucleoplasm, alongside its centrosomal localization, indicating roles in RNA and cilia metabolism. We show dysregulation of U4 snRNA in patient cells and dysregulation in both gene expression and spliceosome activity within the mutant mouse retina, impacting key processes such as photoreceptor light responses, RNA regulation, and primary cilia-associated metabolism. These results highlight GPATCH11 roles in RNA metabolism, spliceosome regulation, and potential ciliary involvement. They underscore its significance in maintaining proper gene expression, contributing to retinal, neurological, and skeletal functions. Our research also demonstrates how studying rare genetic disorders can reveal broader gene functions, providing insights into GPATCH11 multifaceted roles.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
PLOS Genetics
756 papers in training set
Top 0.7%
12.7%
2
Human Molecular Genetics
130 papers in training set
Top 0.1%
12.3%
3
eLife
5422 papers in training set
Top 6%
10.1%
4
Nature Communications
4913 papers in training set
Top 21%
9.1%
5
Developmental Cell
168 papers in training set
Top 4%
4.8%
6
Scientific Reports
3102 papers in training set
Top 28%
4.3%
50% of probability mass above
7
iScience
1063 papers in training set
Top 3%
4.0%
8
NAR Molecular Medicine
18 papers in training set
Top 0.1%
3.9%
9
Nucleic Acids Research
1128 papers in training set
Top 6%
3.6%
10
The American Journal of Human Genetics
206 papers in training set
Top 1%
3.2%
11
npj Genomic Medicine
33 papers in training set
Top 0.3%
1.9%
12
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 35%
1.5%
13
Cell Genomics
162 papers in training set
Top 4%
1.5%
14
Genes
126 papers in training set
Top 1%
1.3%
15
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 6%
1.2%
16
Cell Death & Disease
126 papers in training set
Top 2%
0.9%
17
Genome Medicine
154 papers in training set
Top 6%
0.9%
18
International Journal of Molecular Sciences
453 papers in training set
Top 12%
0.9%
19
Aging Cell
144 papers in training set
Top 3%
0.9%
20
Frontiers in Genetics
197 papers in training set
Top 8%
0.9%
21
Nature Genetics
240 papers in training set
Top 6%
0.9%
22
Neurobiology of Disease
134 papers in training set
Top 4%
0.9%
23
Cells
232 papers in training set
Top 6%
0.8%
24
Life Science Alliance
263 papers in training set
Top 1%
0.8%
25
Human Genomics
21 papers in training set
Top 0.4%
0.7%
26
EMBO Molecular Medicine
85 papers in training set
Top 4%
0.7%
27
Genomics
60 papers in training set
Top 3%
0.7%
28
Human Genetics
25 papers in training set
Top 0.5%
0.7%
29
Pigment Cell & Melanoma Research
11 papers in training set
Top 0.1%
0.6%
30
JCI Insight
241 papers in training set
Top 8%
0.6%